Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.8mm RC, SLA? 12mm, TiZr, NTP: medical device reports filed with FDA

2,175 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,175
device reports naming the brand
0% of all MAUDE reports · about 319 a year
253
reports, 12 months to August 2026
408 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,175 reports that name the brand "BL, ? 4.8mm RC, SLA? 12mm, TiZr, NTP" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

253 reports arrived in the 12 months to August 2026, down 38% from 408 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (62%), loss of osseointegration (24.5%) and difficult to insert (2.9%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

054107Sep 2021: 22Oct 2021: 30Nov 2021: 18Dec 2021: 122022Jan 2022: 28Feb 2022: 15Mar 2022: 22Apr 2022: 15May 2022: 49Jun 2022: 22Jul 2022: 19Aug 2022: 37Sep 2022: 46Oct 2022: 45Nov 2022: 19Dec 2022: 232023Jan 2023: 32Feb 2023: 31Mar 2023: 17Apr 2023: 14May 2023: 20Jun 2023: 20Jul 2023: 13Aug 2023: 14Sep 2023: 23Oct 2023: 32Nov 2023: 13Dec 2023: 112024Jan 2024: 30Feb 2024: 16Mar 2024: 15Apr 2024: 20May 2024: 21Jun 2024: 17Jul 2024: 40Aug 2024: 25Sep 2024: 18Oct 2024: 107Nov 2024: 52Dec 2024: 262025Jan 2025: 30Feb 2025: 24Mar 2025: 24Apr 2025: 24May 2025: 0Jun 2025: 62Jul 2025: 16Aug 2025: 25Sep 2025: 14Oct 2025: 16Nov 2025: 18Dec 2025: 172026Jan 2026: 11Feb 2026: 18Mar 2026: 15Apr 2026: 20May 2026: 31Jun 2026: 31Jul 2026: 19Aug 2026: 43

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01943872019: 17920192020: 30020202021: 27120212022: 34020222023: 24020232024: 38720242025: 27020252026: 1882026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,175
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report86.1%1,872
Voluntary report0%0
User facility report0%0
Distributor report13.9%303
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,34862%62.8%
Loss of osseointegration53224.5%22.4%
Difficult to insertthe device was hard to insert642.9%0.4%
Separation failure100.5%0.1%
Fracturea broken bone80.4%1.6%
Unintended movement30.1%0%
Therapeutic or diagnostic output failure20.1%0%
Activation, positioning or separation problem10%0%
Difficult to removethe device was hard to remove10%0%
Output problem10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis73033.6%
Painpain, site not specified52224%
Tissue damage29313.5%
Inflammationinflammation1567.2%
Hemorrhage/blood loss/bleeding1506.9%
Swelling/ edema1034.7%
Fistula673.1%
Abscessa collection of pus663%
Hyperresponsive to stimuli562.6%
Swellingswelling281.3%
Failure of implant261.2%
Hypersensitivity/allergic reaction190.9%
Inadequate osseointegration120.6%
Numbnessnumbness120.6%
Sinus perforation60.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.8mm RC, SLA? 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports2,1753,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer86.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.8mm RC, SLA? 12mm, TiZr, NTP reports

How many FDA reports name BL, ? 4.8mm RC, SLA? 12mm, TiZr, NTP?

2,175 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 253 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (62%), loss of osseointegration (24.5%), difficult to insert (2.9%), separation failure (0.5%) and fracture (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (86.1%) and distributor reports (13.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.8mm RC, SLA? 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.